Browse > Article

CCNU, Vinblastine and Prednisone Treatment for Grade II Dermal Mast Cell Tumor in a Yorkshire terrier dog  

Seo, Kyoung-Won (College of Veterinary Medicine, Seoul National University)
Lee, Jong-Bok (College of Veterinary Medicine, Seoul National University)
Kim, Seoung-Soo (College of Veterinary Medicine, Seoul National University)
Bhang, Dong-Ha (College of Veterinary Medicine, Seoul National University)
Jung, Jin-Young (College of Veterinary Medicine, Seoul National University)
Hwang, Cheol-Yong (College of Veterinary Medicine, Seoul National University)
Kim, Dae-Yong (College of Veterinary Medicine, Seoul National University)
Youn, Hwa-Young (College of Veterinary Medicine, Seoul National University)
Lee, Chang-Woo (College of Veterinary Medicine, Seoul National University)
Publication Information
Journal of Veterinary Clinics / v.24, no.4, 2007 , pp. 618-621 More about this Journal
Abstract
An 11-year-old, castrated male Yorkshire terrier dog was presented with multiple plaques on right inguinal region. Grade II mast cell tumor was diagnosed. The dog was treated with Vinblastine and prednisone(PDS) initially. Because of poor response of the dog, CCNU was added for more aggressive treatment. After 5 weeks treatment of with CCNU, vinblastine and PDS, the lesion was improved. Moderate leukopenia was shown after 4 cycles of chemotherapy. The chemotherapy was re-administered since the patient recovered from the leukopenia. Though the same protocol was applied, no improvement of the lesion was observed. Moreover, the general body condition of the dog became worse and was euthanized by the owner's request. Necropsy was not permitted. The survival time was 330 days after start of the chemotherapy.
Keywords
CCNU; chemotherapy; dog; mast cell tumor;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Moore AS, London CA, Wood CA, Williams LE, Cotter SM, L'Heureux DA, Frimberger AE. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs. J Vet Intern Med 1999; 13: 395-398   DOI
2 Frimberger AE, Moore AS, LaRue SM, Gliatto JM, Bengtson AE. Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989- 1993). J Am Anim Hosp Assoc 1997;.33: 320-324
3 Bostock DE. The prognosis following surgical removal of mastocytomas in dogs. J Small Anim Pract 1973; 14: 27-41   DOI   ScienceOn
4 Williams LE, Rassnick KM, Power HT, Lana SE, Morrison-Collister KE, Hansen K, Johnson JL. CCNU in the treatment of canine epitheliotropic lymphoma. J Vet Intern Med 2006; 20: 136-143   DOI
5 Gieger TL, Theon AP, Werner JA, McEntee MC, Rassnick KM, DeCock HE. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990- 2001). J Vet Intern Med 2003; 17: 687-692
6 Kristal O, Rassnick KM, Gliatto JM, Northrup NC, Chretin JD, Morrison-Collister K, Cotter SM, Moore AS. Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs. J Vet Intern Med 2004; 18: 75-80   DOI
7 Bostock DE, Crocker J, Harris K, Smith P. Nucleolar ornagiser regions as indicators of post-surgical prognosis in canine spontaneous mast cell tumours.Br J Cancer 1989; 59: 915-918   DOI   ScienceOn
8 Turrel JM, Kitchell BE, Miller LM, Theon A. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs. J Am Vet Med Assoc 1988; 193: 936-940
9 Thamm DH, Mauldin EA, Vail DM. Prednisone and vinblastine chemotherapy for canine mast cell tumor--41 cases (1992-1997). J Vet Intern Med 1999; 13: 491-497
10 Rassnick KM, Moore AS, Williams LE, London CA, Kintzer PP, Engler SJ, Cotter SM. Treatment of canine mast cell tumors with CCNU (lomustine). J Vet Intern Med 1999; 13: 601-605   DOI
11 B L. Some aspects of mastocytoma. Nord Vet med 1957; 9: 241-256
12 Patnaik AK, Ehler WJ, MacEwen EG. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 1984; 21: 469-474   DOI
13 Macy DW. Canine mast cell tumors. Vet Clin North Am Small Anim Pract 1985; 15: 783-803   DOI
14 Hahn KA, King GK, Carreras JK. Efficacy of radiation therapy for incompletely resected grade-III mast cell tumors in dogs: 31 cases (1987-1998). J Am Vet Med Assoc 2004; 224: 79-82   DOI   ScienceOn
15 Al-Sarraf R, Mauldin GN, Patnaik AK, Meleo KA. A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs. J Vet Intern Med 1996; 10: 376-378   DOI   ScienceOn
16 O'Keefe DA. Canine mast cell tumors. Vet Clin North Am Small Anim Pract 1990; 20: 1105-1115   DOI
17 Seguin B, Besancon MF, McCallan JL, Dewe LL, Tenwolde MC, Wong EK, Kent MS. Recurrence rate, clinical outcome, and cellular proliferation indices as prognostic indicators after incomplete surgical excision of cutaneous grade II mast cell tumors: 28 dogs (1994-2002). J Vet Intern Med 2006; 20: 933-940
18 Sfiligoi G, Rassnick KM, Scarlett JM, Northrup NC, Gieger TL. Outcome of dogs with mast cell tumors in the inguinal or perineal region versus other cutaneous locations: 124 cases (1990-2001). J Am Vet Med Assoc 2005; 226: 1368- 1374   DOI   ScienceOn
19 Vail DM: Mast cell tumors., In: Small animal clinical oncology, 3rd ed. Philadelphia: WB Saunders.2001: 261-282
20 Cahalane AK, Payne S, Barber LG, Duda LE, Henry CJ, Mauldin GE, Frimberger AE, Cotter SM, Moore AS. Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994-2002). J Am Vet Med Assoc 2004; 225: 401-408   DOI   ScienceOn
21 Scase TJ, Edwards D, Miller J, Henley W, Smith K, Blunden A, Murphy S. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis. Vet Intern Med 2006; 20: 151-158   DOI